GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Other Current Payables

ANL (Adlai Nortye) Other Current Payables : $3.79 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye Other Current Payables?

Adlai Nortye's Other Current Payables for the quarter that ended in Jun. 2024 was $3.79 Mil.

Adlai Nortye's quarterly Other Current Payables declined from Jun. 2023 ($9.74 Mil) to Dec. 2023 ($4.12 Mil) and declined from Dec. 2023 ($4.12 Mil) to Jun. 2024 ($3.79 Mil).

Adlai Nortye's annual Other Current Payables increased from Dec. 2021 ($3.22 Mil) to Dec. 2022 ($3.88 Mil) and increased from Dec. 2022 ($3.88 Mil) to Dec. 2023 ($4.12 Mil).

Adlai Nortye Other Current Payables Historical Data

The historical data trend for Adlai Nortye's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye Other Current Payables Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23
Other Current Payables
3.22 3.88 4.12

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23 Jun24
Other Current Payables Get a 7-Day Free Trial 3.88 4.52 9.74 4.12 3.79

Adlai Nortye Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Adlai Nortye Other Current Payables Related Terms

Thank you for viewing the detailed overview of Adlai Nortye's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Adlai Nortye Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Other Current Payables
Comparable Companies
MGTX KALV JANX AVTE ABUS VYGR BLUE AGEN FUSN CRBU OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
685 US Highway 1, New Jersey Biotechnology Development Center, 2nd floor, North Brunswick, NJ, USA, 08902
Website
https://www.adlainortye.com
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.